Antisense Oligo-Mediated Multiple Exon Skipping in a Dog Model of Duchenne Muscular Dystrophy

Methods in Molecular Biology - United States
doi 10.1007/978-1-61737-982-6_20
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Humana Press

Related search

Efficacy of Multi-Exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model Neonates

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2019English

Prednisolone Treatment Does Not Interfere With 2′-O-Methyl Phosphorothioate Antisense-Mediated Exon Skipping in Duchenne Muscular Dystrophy

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2012English

Exon Skipping: A First in Class Strategy for Duchenne Muscular Dystrophy

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2016English

Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy

PLoS ONE
Multidisciplinary
2014English

Dual Exon Skipping in Myostatin and Dystrophin for Duchenne Muscular Dystrophy

BMC Medical Genomics
Genetics
2011English

Intravenous Infusion of an Antisense Oligonucleotide Results in Exon Skipping in Muscle Dystrophin mRNA of Duchenne Muscular Dystrophy

Pediatric Research
Child HealthPediatricsPerinatology
2006English

A Multicenter Comparison of Quantification Methods for Antisense Oligonucleotide-Induced DMD Exon 51 Skipping in Duchenne Muscular Dystrophy Cell Cultures

PLoS ONE
Multidisciplinary
2018English

Autoimmune Response and Its Long‐term Consequences After Exon‐skipping Therapy in a Duchenne Muscular Dystrophy Mouse Model

Journal of Pathology
Forensic MedicinePathology
2019English

136. First-In-Human Study of NS-065/NCNP-01; The Morpholino Based Antisense Oligonucleotide for Exon 53 Skipping in Duchenne Muscular Dystrophy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy